CVS Health stock slips to EUR 80.69, down 0.65% premarket
Published on 11/02/2026 at 07:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey Points For Investors
- CVS Health is due to report third-quarter results before US markets open on Wednesday, November 4.
- The healthcare group combines insurance, pharmacy benefit management and retail health services.
Earnings Loom This Week
CVS Health stock traded at EUR 80.69 on Lang & Schwarz at 07:41 CET on Monday, November 2, 2026, 0.65 percent below the Xetra close of Friday, October 30, at EUR 81.22.
The company is scheduled to release its third-quarter results before US markets open on Wednesday, November 4. The report will give investors a fresh view of operating performance across its insurance, pharmacy benefit management and retail health businesses.
Management guidance and the outlook for the remainder of 2026 are likely to shape the next stage of the investment debate. Investors will also watch whether the earnings release provides further detail on the group's cost base, medical trends and cash generation.
Investors can follow the real-time quote of CVS Health stock during the European session.
The broader US market can be followed through the S&P 500.
More news and analysis are available on CVS Health stock.
